This garment aids in healing and helps the skin adjust to its new shape
Beyond-use date (BUD)
Regularly descale the cooling tower to prevent scaling issues
Disclosure of interest: Pier Andrea Rizzo: nothing to disclose Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P1074 - ESOC25-2189 ACTIVATED LEUCOCYTE CELL ADHESION MOLECULE IN MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION Alejandro Rodrguez Vzquez 1,2,3 , Andrea Cabero-Arnold 1,2 , Carlos Laredo 1,2 , Monica Serrano 1 , Yolanda Gonzlez Romero 1 , Antonio Doncel-Moriano 1 , Salvatore Rudilosso, Sergio Amaro, Arturo Ren 1 , Laura Llull, Angel Chamorro 1 , Francisco Lozano 2,4 , Xabier Urra 1 1 Comprehensive Stroke Center, Hospital Clnic de Barcelona, Barcelona, Spain, 2 Fundaci de Recerca Clnic Barcelona - Institut d'Investigacins Biomdiques August Pi i Sunyer, Barcelona, Spain, 3 Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain, 4 Centre de Diagnstic Biomdic, Hospital Clnic de Barcelona, Barcelona, Spain Background and Aims: Malignant cerebral infarction (MCI) is a devastating situation with no effective treatment besides hemicraniectomy
2390 3590 1200 : 2790 BPC-157 (Body Protective Compound 157) 15 , ,
In experimental models, these peptides are studied together for their potential roles in cell migration, extracellular matrix remodeling, and skin and connective-tissue signaling processes
